
Müschen Lab
@muschenlab
B-cell dynamics, oncogenic signaling in B-cell malignancies @YaleUniversity #StopAAPIHate
ID: 1353831621032603652
https://medicine.yale.edu/profile/markus_muschen/ 25-01-2021 22:26:55
302 Tweet
751 Followers
286 Following



Excited our final version of Christine Isadora Ng's work on targeted protein relocalization is out today @nature! Molecular control over protein localization could offer new opportunities for therapeutics and biological discovery. Sarafan ChEM-H Stanford Chemistry nature.com/articles/s4158…

Very happy and proud to see this study on PU.1 transcription factor "redistribution" and its mechanistic implications out in Nature Genetics today. Huge congrats to lead author Samuel John Taylor! (recruiters watch out: Sam is on the faculty job market now...!). A big thank you also

Immunologists out there, join us in New York City and NYU Grossman School of Medicine !! All candidates will be considered but the ones with a track record in the development of cutting-edge experimental, engineering and computational approaches to analyze immune responses are particularly


In the Spotlight: Tuning Responses to Polatuzumab Vedotin in B-cell Lymphoma, by Etienne Leveille and colleagues. Müschen Lab Yale University bit.ly/3XPEwKo


Thoroughly enjoyed my visit to Cell Signaling Technology and discovering our many shared priorities. Plus, nothing says “Northeastern Massachusetts” like lush tropical gardens, with Italian espresso machines planted throughout the atrium.




Leo Meriranta Leo Meriranta is defending his PhD thesis “molecular cross-section of high/risk #DLBCL” today. It is an honor to chair and enjoyable to listen high level scientific discussion lead by Dr Dan Hodson. Thank you Dan, well done Leo!



Wonderful to be hosting Michael Reth National Academy of Sciences , who discovered the ITAM and pioneer in immune receptor signaling. Thank you for an inspirational seminar Yale Department of Immunobiology and private brainstorming session over breakfast.





Zhangliang Cheng Müschen Lab presents on the 3 stages of B Cells and oscillations between MYC and BCL6 dependent states in B Cell #lymphoma. #ASH24 Yale School of Medicine Smilow Cancer Hospital


.Ruifeng Sun presents research Müschen Lab showing CD25 as a regulator of the B pathway and suggesting it as a new therapeutic target for acute lymphoblastic leukemia #ALL at #ASH24. YaleHematology OncoAlert Yale School of Medicine Yale Department of Immunobiology ash.confex.com/ash/2024/webpr…


New research presented at #ASH24 from the Müschen Lab by Ruifeng Sun shows the previously unrecognized role of PKCδ and CD25 in to control BCR signaling in Mature B-Cell #Lymphoma. Yale School of Medicine OncoAlert YaleHematology ash.confex.com/ash/2024/webpr…


